Lantus Solostar

Product NDC
70518-1390
11-digit product format
705181390
Labeler code
70518
Product ID
70518-1390_c287e75d-7a1e-8fdd-e053-2995a90a9881
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
insulin glargine
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Labeler
REMEDYREPACK INC.
Application
BLA021081
Marketing category
BLA
Marketing start
2018-08-28
Marketing end
0000-00-00
Substance
INSULIN GLARGINE
Active strength
100 [iU]/mL
Pharmacologic classes
Insulin [Chemical/Ingredient],Insulin Analog [EPC]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70518-1390-02021-05-17C16284748780-19d75b9d0-90b5-f424-e053-dadaa90a57ce3e2d9cf8-0952-4361-8e87-cd5c380ad485
70518-1390-02020-01-31C16284748780-19d75b9d0-90b5-f424-e053-dadaa90a57ce3e2d9cf8-0952-4361-8e87-cd5c380ad485

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-1390-0705181390005 SYRINGE in 1 PACKAGE (70518-1390-0) > 3 mL in 1 SYRINGE5 syringe2018-08-280000-00-00NoNoCurrent